Buying an SUD treatment facility

Buying·Last updated Sep 14, 2026

Buying, leasing, or converting property for addiction treatment requires separate review of the site and the proposed treatment operation. This guide is a starting point for site selection, due diligence, licensing, operations, and acquisition risk.

Define the proposed service before selecting property

Substance use disorder treatment can include outpatient counseling, intensive outpatient services, residential care, withdrawal management, and opioid treatment programs. These are not interchangeable uses. The service model, overnight occupancy, resident ability to evacuate, medication activity, staffing, and bed count shape the property review.

Buying, leasing, or converting

Buying

Ownership can provide control over alterations and long-term occupancy, but it also places approval, retrofit, financing, environmental, and exit risk on the buyer.

Leasing

Leasing can reduce initial property capital, but the term, renewal rights, improvement allowance, use clause, licensing contingencies, assignment rights, and landlord consent can determine whether the site remains usable.

Converting

A house, assisted-living property, hotel, school, or other building may be a candidate for conversion. Prior use is not proof of compatibility. A buyer must verify zoning, occupancy classification, egress, sprinklers, accessibility, resident safety, utilities, parking, and the target state's physical-plant rules.

Property due diligence

• Title, survey, easements, deed restrictions, legal access, utilities, and parking.
• Property-condition, roof, structure, mechanical, electrical, plumbing, and sewer capacity.
• Phase I environmental site assessment and any recommended follow-up.
• Accessibility, fire protection, alarm, egress, occupancy load, bedroom, bathroom, and common-area review.
• Written land-use analysis for the exact treatment model, resident count, and operational plan.
• Costed scope and schedule for required improvements, including contingency.

Licensing and operational due diligence

State licensure, local land use, building approval, accreditation, controlled-substance requirements, and payer enrollment are separate workstreams. For opioid treatment programs, CMS states that Medicare enrollment depends on full SAMHSA certification and accreditation by a SAMHSA-approved body. Requirements differ for other SUD services and must be checked with the relevant agencies and payers.

• Identify the license holder, status, scope, capacity, conditions, and change-of-ownership process.
• Review surveys, plans of correction, complaints, sanctions, exclusions, and litigation.
• Verify accreditation and payer participation directly with each organization.
• Review staffing, clinical leadership, referral concentration, billing, denials, collections, and working capital.
• Confirm whether any certificate-of-need or similar approval applies in the target state.

Information that requires independent verification

Buyer interest, transaction activity, valuations, cap rates, multiples, reimbursement, market demand, retrofit costs, and projected returns are time-sensitive and deal-specific. No third-party article, listing, prior license, or seller statement proves that a buyer can legally operate, obtain reimbursement, or earn a return at a property.

Sources and starting points

• Behave Health: Treatment Center Real Estate Guide — third-party operational context; verify independently.
• SAMHSA: 2024 treatment-facility survey release.
• CMS: opioid treatment program enrollment.
• DOJ and HUD: local land use and the Fair Housing Act.
• NCSL: certificate-of-need state laws.

Last researched: September 14, 2026.